Page last updated: 2024-08-25

cromakalim and Gastric Diseases

cromakalim has been researched along with Gastric Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abban, G; Akar, F; Buharalioğlu, CK; Heinemann, A; Holzer, P; Uydeş-Doğan, BS; Van de Voorde, J	1

Other Studies

1 other study(ies) available for cromakalim and Gastric Diseases

Article	Year
Protective effect of cromakalim and diazoxide, and proulcerogenic effect of glibenclamide on indomethacin-induced gastric injury. European journal of pharmacology, 1999, Jun-25, Volume: 374, Issue:3 Topics: Animals; Arteries; Blood Glucose; Blood Pressure; Cromakalim; Diazoxide; Dose-Response Relationship, Drug; Gastric Mucosa; Gastrointestinal Agents; Glyburide; Hypoglycemic Agents; Indomethacin; Male; Neutrophils; Peroxidase; Rats; Regional Blood Flow; Stomach; Stomach Diseases; Vasodilation; Vasodilator Agents	1999

Article

Year

Protective effect of cromakalim and diazoxide, and proulcerogenic effect of glibenclamide on indomethacin-induced gastric injury.

European journal of pharmacology, 1999, Jun-25, Volume: 374, Issue:3

Topics: Animals; Arteries; Blood Glucose; Blood Pressure; Cromakalim; Diazoxide; Dose-Response Relationship, Drug; Gastric Mucosa; Gastrointestinal Agents; Glyburide; Hypoglycemic Agents; Indomethacin; Male; Neutrophils; Peroxidase; Rats; Regional Blood Flow; Stomach; Stomach Diseases; Vasodilation; Vasodilator Agents

1999